Last Updated:
Access Report
Name Designation Appointment Date Status
Anant Kumar Agrawal

Appointed as Director since August 2019

 Director 19-Aug-2019 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Vijay Kumar Agrawal

Appointed as Director since November 2022

 Director 11-Nov-2022 Current

People Timeline

Explore the timeline of key personnel in Nuthelia Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address W/O Sh Tej Pal Sharma, E-103-A, F/F, Khno-162/1, Gali No. 3, Ph-1, Bhagirathi, Vihar Near, Delhi Delhi, 110094, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110094
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Nuthelia Pharmaceuticals Private Limited?
You can contact Nuthelia Pharmaceuticals Private Limited through their registered address at W/O Sh Tej Pal Sharma, E-103-A, F/F, Khno-162/1, Gali No. 3, Ph-1, Bhagirathi, Vihar Near, Delhi Delhi, 110094, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Nuthelia Pharmaceuticals Private Limited?
The current directors of Nuthelia Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ANANT KUMAR AGRAWAL
  • VIJAY KUMAR AGRAWAL
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available